Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2025 06:00 ET | Source: Er-Kim Pharmaceuticals

Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients

Er-Kim and Puma Biotechnology sign agreement to commercialize NERLYNX® (neratinib) in select countries in Eastern Europe and Central Asia
April 15, 2025 09:26 ET | Source: Er-Kim Pharmaceuticals

Er-Kim Announces Exclusive Distribution Agreement with Polaris Pharmaceuticals to Commercialize Pegargiminase (ADZODI) for Malignant Pleural Mesothelioma (MPM) in Multiple EMEA Markets

Er-Kim signs distribution agreement with Polaris Pharmaceuticals to commercialize Pegargiminase (ADZODI) across 36 markets in the EMEA region